28/05/2020
The first GLP-1 agonist pill for Type 2 diabetes has been approved by the European Medicines Agency (EMA). Rybelsus (known …
While diabetes has traditionally been the focus of blood glucose management, Afon Technology is encouraging a shift to …
Ypsomed is to expand its offering of digital health solutions in partnership with S3 Connected Health. Headquartered in …